City Therapeutics (CTY) files S-1 for Nasdaq IPO with Goldman-led syndicate

As seen on the 24/7 Wall St. homepage on September 24, 2026.

THE IPO WIRE
City Therapeutics, Inc. CTY · Nasdaq

City Therapeutics files for Nasdaq IPO with a four-bank syndicate led by Goldman Sachs

City Therapeutics has filed its S-1 to list on Nasdaq, with Goldman Sachs, Jefferies, Stifel and Oppenheimer running the books. Terms and deal size are not set yet, so the price range in the first amendment is the number that will define this one.

Continue ReadingShow less

City Therapeutics, Inc. has submitted its S-1 registration statement to the SEC, formally starting the clock on what would be a Nasdaq debut. The filing marks the transition from private company to public candidate, triggering the SEC review process that must conclude before shares can trade.

Goldman Sachs is leading the four-bank syndicate alongside Jefferies, Stifel, and Oppenheimer. That combination of a bulge-bracket lead with three active healthcare-focused underwriters signals the company is positioning for both institutional depth and sector-specialist coverage in the roadshow.

Sponsored

No price range, share count, or deal size has been disclosed in this initial filing. Those terms will land in the first amendment to the S-1, and that document is the one that will define valuation expectations for prospective investors.

Until the amended filing arrives with a price range, the core due-diligence work for anyone tracking this offering is the S-1 itself, available through the SEC's EDGAR system, where the company's financials, risk factors, and business description are laid out in full.

Sources

Related Market Updates

TRGP Targa Resources
After-hours
$294.79
-5.62% open $312.34

A 5.62% drop to $294.79 is an outsized one-day move for a $63 billion midstream name usually bought for its steadiness. Watch whether the $312.34 open holds as resistance from here.

Read more
Market explainer · After the close

US stocks are mixed as Technology lags and Financials leads

  • S&P 500-0.5%
  • Nasdaq 100-1.4%
  • Dow+0.4%
  • Russell 2000-0.1%

Per CNBC, tech melted down again as the Nasdaq fell about 1%, while the Dow rose.

LeadingConsumer Discretionary +2.4%Financials +1.9%Materials +1.8%
LaggingEnergy -4.0%Technology -2.9%Health Care -0.1%
Sources
Read more
UPST Upstart
After-hours
$21.31
-8.89% open $23.39
$22$22$21

An 8.9% slide off the $23.39 open leaves the AI lender at $21.31 and a $2.1 billion market cap, a reminder of how little cushion this name carries in after-hours trade. Where it settles at the next open is the number that matters.

Read more
NEW ETF LAUNCHES 1 new ETF hit the market · Nov 2
  • VTVXXFUNDS™ Value Income ETFequity0.78%

Just one new fund cleared EDGAR on Monday: the XFUNDS Value Income ETF, an actively run equity-income play charging 0.78% net. A premium price tag in a category where plain value exposure runs a fraction of that.

Read more
Biggest movers · At the close
Gainers
  • IDXXIDEXX Laboratories$671.82+21.9%
  • TEMTempus AI$79.36+9.9%
  • RIVNRivian$13.1+7.7%
  • HWMHowmet Aerospace$212.78+6.8%
  • BAMBrookfield Asset Management$51.37+6.4%
Losers
  • LITELumentum$683.66-18.7%
  • MRVLMarvell Technology$171.11-12.9%
  • ALABAstera Labs$229.63-11.2%
  • AAOIApplied Optoelectronics$62.38-9.7%
  • CRWVCoreWeave$49.85-9.2%

IDEXX Laboratories closed up 21.88%, the single largest move in a 383-name universe. Lumentum and Marvell sat at the other end of the session.

Read more
BSX Boston Scientific
After-hours
$44.12
+4.59% open $42.18
$44$44$44

A 4.59% run to $44.12 adds close to $3 billion of market value to a $63.9 billion medtech name that rarely moves this much in a single session. Whether the gain holds through the next open is the tell.

Read more
NTRA Natera
After-hours
$380.71
-8.40% open $415.64
$386$382$377

An 8.4% slide to $380.71 takes roughly $5 billion off Natera's $54.9 billion market cap in a single session. Moves this big are rare for a name this size, so watch whether the $415 open gets reclaimed.

Read more
PLTR Palantir
After-hours
$178.46
-3.07% open $184.11
$183$181$178

A 3.07% slide to $178.46 trims roughly $13 billion off a $412 billion market cap, and it lands in after-hours trading. Keep an eye on where the stock settles.

Read more
CLOSING BELL
U.S. Markets
  • S&P 500-0.50%
  • Dow Jones Industrial Average+0.82%
  • Nasdaq Composite-0.95%

Money rotated out of tech today: the Dow and Nasdaq split by 1.7 points, a sign investors are paying up for old-economy cash flows. If you only track the S&P 500, you missed the handoff entirely.

Read more
IDXX IDEXX Laboratories
Regular session
$669.00
+7.04% open $625.00
$673$654$635

A 7.04% jump to $669 follows the Q3 earnings beat, a rare one-day move for a $52.7 billion diagnostics name that usually grinds rather than gaps. Keep an eye on whether it holds the level into the close.

Read more
TDG TransDigm Group
Regular session
$1209.73
+4.38% open $1158.96
$1.2k$1.2k$1.2k

A 4.38% intraday climb to $1,209.73 adds roughly $2.9 billion to this $67.7 billion aerospace supplier, a big single-day swing for a name that usually grinds higher. Whether it holds the $1,200 handle into the close is the thing to watch.

Read more
CRH CRH
Regular session
$96.61
+4.33% open $92.60
$97$95$93

A 4.33% intraday run to $96.61 adds roughly $2.7 billion to a $64.3 billion building materials giant that rarely moves this much in a single session. Worth seeing whether the close holds above the $92.60 open.

Read more